| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |